Arbutus Biopharma Corporation
Substituted 2,3-dihydro-1H-indene analogs and methods using same
Last updated:
Abstract:
The present invention includes substituted 2,3-dihydro-1H-indene analogs, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient.
Status:
Grant
Type:
Utility
Filling date:
24 Apr 2018
Issue date:
28 Sep 2021